Loading...
6 Recombinant Products Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East, South America
Major Players: Eli Lilly and Company, Thermo Fisher Scientific, Novartis, GlaxoSmithKline, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Illumina, Eurofins, Roche, Natera, Inc., Biodesix
.webp){kind=logo}
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: New England Biolabs, Sanofi, Genscript, GlaxoSmithKline, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Transgene, Sorrento Therapeutics, Amgen, CG Oncology, Oncolys BioPharma
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Eli Lilly and Company, Ferring Pharmaceuticals, Roche, Merck, Pfizer
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Novo Nordisk, Eli Lilly and Company, Sanofi, Zhuhai United Laboratories, Biocon Ltd
Filter Reports
By Region
By Countries
